Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial.
Ceramide Synthase 6 Plays a Critical Role in the Development of Experimental Autoimmune Encephalomyelitis.
B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis.
Clinical overview of the seizure risk of dalfampridine.
Administration of monthly-pulse cyclophosphamide in multiple sclerosis patients. Effects of long-term treatment on immunologic parameters.
Imaging robust microglial activation after lipopolysaccharide administration in humans with PET.
Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort.
FDA warns about seizures linked to MS drug
Use of population based background rates of disease to assess vaccine safety in childhood and mass immunisation in Denmark: nationwide population based cohort study.
Incidence of multiple sclerosis in the United Kingdom : findings from a population-based cohort.
Laquinimod for multiple sclerosis.
Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis.
Stress and the risk of multiple sclerosis.
Optimizing parameter choice for FSL-Brain Extraction Tool (BET) on 3D T1-images in multiple sclerosis.
Effect of met-enkephalin on chromosomal aberrations in the lymphocytes of the peripheral blood of patients with multiple sclerosis.
Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality.
LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex.
Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome.
Function and distribution of three types of rectifying channel in rat spinal root myelinated axons.
Double Blind Combination of Rituximab by Intravenous and Intrathecal Injection Versus Placebo in Patients With Low-Inflammatory Secondary Progressive Multiple Sclerosis (RIVITaLISe)
Associations of CD6, TNFRSF1A, and IRF8 polymorphisms with risk of inflammatory demyelinating diseases.
CLARITY – Safety and Efficacy of Oral Cladribine in Subjects with Relapsing-remitting Multiple Sclerosis (MS)
Super-resolution imaging of aquaporin-4 orthogonal arrays of particles in cell membranes.
The extent of ultrastructural spinal cord pathology reflects disease severity in experimental autoimmune encephalomyelitis.
Narcolepsy with cataplexy and comorbid immunopathological diseases.

Pages